Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Current Treatment Options in Oncology|January 25, 2024
Steroid Premedication and Monoclonal Antibody Therapy: Should We Reconsider?Emma-Anne Karlsen, Euan Walpole, Fiona Simpson
Breast Cancer Research and Treatment|August 25, 2012
Effect of obesity on toxicity in women treated with adjuvant chemotherapy for early-stage breast cancer: a systematic reviewJames Carroll, Melinda Protani, Euan Walpole, et al.
Internal Medicine Journal|October 18, 2020
End-of-life intravenous chemotherapy administration patterns in the treatment of Queensland lung and pancreas cancer patients: a 10-year retrospective analysisMichael J Allen, Nathan Dunn, Tracey Guan, et al.
Australian Health Review : a Publication of the Australian Hospital Association|January 27, 2021
Research governance authorisation: the next frontierSamantha Hollingworth, Dan Mckavanagh, Ian McPherson, et al.
International Journal of Clinical Pharmacy|June 3, 2017
Using pharmacy management systems for research: survival outcomes for lenalidomide in multiple myeloma in the clinical settingMegan M Sharkey, Daniel McKavanagh, Euan Walpole, et al.
Anti-Cancer Drugs|August 16, 2018
Survival outcomes in patients with non-small-cell lung cancer treated with erlotinibAlexandria C McGrath, Geeta Sandhu, Euan Walpole, et al.
Pharmacoepidemiology and Drug Safety|April 11, 2021
Survival of advanced melanoma patients treated with immunotherapy and targeted therapy: A real-world studySu-Yeon Yu, Dan Mckavanagh, Ian McPherson, et al.
JAMA Dermatology|February 12, 2025
Immune Checkpoint Inhibitors in Field Cancerization and Keratinocyte Cancer PreventionCharlotte Cox, Susan Brown, Euan Walpole, et al.
Journal of Adolescent and Young Adult Oncology|May 11, 2018
Queensland Youth Cancer Service: A Partnership Model to Facilitate Access to Quality Care for Young People Diagnosed with CancerNatalie K Bradford, Roslyn Henney, Rick Walker, et al.
Asia-Pacific Journal of Clinical Oncology|July 21, 2016
Effectiveness of bevacizumab and cetuximab in metastatic colorectal cancer across selected public hospitals in QueenslandSuzannah J Chapman, Daniel McKavanagh, Matthew E Burge, et al.
Pageof 4